IP Library Granted Patent US 10,155,101
Granted Patent B2
US 10,155,101 · App. 15/660,513 · Granted Dec 18, 2018

Overmolded access port including anchoring and identification features

Inventors: Martha R. Wiley (Salt Lake City, UT); Jodie L. Noyce (Salt Lake City, UT); David M. Cise (Herriman, UT); William R. Barron (Riverton, UT); Kelly J. Christian (Draper, UT); Amir Orome (Sandy, UT)
Assignee: Bard Peripheral Vascular, Inc.
A61M39/0208A61M2039/0009A61M2039/0081A61M2039/0205A61M2039/0223A61M2039/0238Y10T29/49826
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,155,101
App. No.
15/660,513
Granted
Dec 18, 2018
Kind
B2
Abstract

An access port for providing subcutaneous access to a patient is disclosed. In one embodiment, the port includes an internal body defining a fluid cavity that is accessible via a septum. A compliant outer cover including silicone is disposed about at least a portion of the body. A flange is included with the port body and is covered by the outer cover. The flange radially extends about a perimeter of the port body proximate the septum so as to impede penetration of a needle substantially into the outer cover in instances where the needle misses the septum. The flange can further include both an anchoring feature for securing the outer cover to the port body and an identification feature observable via x-ray imaging technology for conveying information indicative of at least one attribute of the access port. The outer cover provides a suitable surface for application of an antimicrobial/antithrombotic coating.

Claims (27)

1. A medical method, comprising:

obtaining a power-injectable access port, comprising:

a body defining a fluid cavity accessible via a septum;

a continuous annular flange circumscribing the septum at a top section of the body proximal of the fluid cavity, the flange formed from a radiopaque material, the flange including one or more identification features that convey to a user that the power-injectable access port is capable of power injection; and

a compliant outer cover disposed about the body and in contact with the flange;

implanting the power-injectable access port in a patient;

connecting a catheter to the power-injectable access port such that a lumen of the catheter is in fluid communication with the fluid cavity; and

identifying the power-injectable access port as capable of power injection by viewing the one or more identification features.

2. The method according to claim 1 , wherein the viewing comprises detecting the one or more identification features on an x-ray image following the implanting step.

3. The method according to claim 1 , wherein the viewing comprises detecting the one or more identification features visually prior to the implanting step.

4. The method according to claim 1 , further comprising accessing the power-injectable access port by inserting a needle transcutaneously through the septum and into the fluid cavity.

5. The method according to claim 4 , further comprising injecting contrast media through the power-injectable access port.

6. The method according to claim 5 , wherein the injecting step comprises injecting contrast media at a rate of up to five milliliters per second.

7. The method according to claim 4 , further comprising aspirating blood through the power-injectable access port.

8. The method according to claim 4 , further comprising infusing medicaments through the power-injectable access port.

9. The method according to claim 1 , wherein the flange is integrally formed with the body.

10. The method according to claim 9 , wherein the flange and the body are formed from a titanium material.

11. The method according to claim 1 , wherein the one or more identification features are openings in the flange, the implanting step including threading one or more sutures through the openings to subcutaneously secure the power-injectable access port to the patient.

12. The method according to claim 1 , wherein the one or more identification features are openings formed into alphanumeric or symbolic characters.

13. The method according to claim 1 , wherein the body is formed from a first material and the flange is formed from a second material different from the first material, and wherein the flange is separate from the body and attached to the body.

14. The method according to claim 13 , wherein the flange includes a plurality of keyed notches that each fit over correspondingly keyed tabs on the body, and wherein the tabs are capable of being deformed after the notches are placed over the tabs such that the flange is retained by the body.

15. The method according to claim 14 , wherein the body includes acetyl resin, and wherein the flange includes titanium.

16. The method according to claim 1 , wherein the flange generally defines a triangular shape including three vertices, and wherein the one or more identification features include alphanumeric indicia disposed at each vertex of the three vertices of the flange.

17. The method according to claim 16 , wherein the alphanumeric indicia are defined as recessed features in the flange, and wherein the flange further comprises a plurality of openings defined through the flange.

18. The method according to claim 1 , wherein the compliant outer cover includes at least one of an antimicrobial component and an antithrombotic component.

19. The method according to claim 1 , wherein the compliant outer cover includes silicone, and wherein at least a portion of a surface of the compliant outer cover is frosted so as to render the portion of the surface substantially opaque.

20. The method according to claim 19 , wherein the compliant outer cover includes silicone mixed with a colorant.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2017
From: WILEY, MARTHA; NOYCE, JODIE L.; CISE, DAVID M.; BARRON, WILLIAM R.; CHRISTIAN, KELLY J.; OROME, AMIR
To: C. R. BARD, INC.
Reel/Frame 043126/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2017
From: C. R. BARD, INC.
To: BARD PERIPHERAL VASCULAR, INC.
Reel/Frame 043129/0328 →
Continuity (4)
Continuation 14750174 · Jun 25, 2015
Continuation 12917323 · Nov 1, 2010
Provisional Application 61262126 · Nov 17, 2009
Related Publication 20170319842A1 · Nov 9, 2017
Cited By (5)
US 12,232,852 US 12,239,811 US 12,343,492 US 12,589,231 US 12,678,103